Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity, generally by electrocardiography, with assessment of the patients condition relative to their cardiac rhythm. It is different from hemodynamic monitoring, which monitors the pressure and flow of blood within the cardiovascular system. The two may be performed simultaneously on critical heart patients. Cardiac monitoring with a small device worn by an ambulatory patient is known as ambulatory electrocardiography. Transmitting data from a monitor to a distant monitoring station is known as telemetry or biotelemetry.
Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014. The other factors boosting the growth of the market studied are - technological advancements, patient awareness, and the increasing number of unmet medical needs in developing and underdeveloped countries.
The Americas witness an increase in the prevalence of CVDs mainly due to the unhealthy lifestyle of the residents. The international vendors such as GE Healthcare and Abbott operate in this region and offer technologically advanced products. US will be the major revenue contributor to the heart monitoring device market.
The report outlines the development of diverse regions and countries by including the market size, volume and value. It also contains the manufacturers data such as batch, price revenue, profit, interview record and business distributors.
The Cardiac Monitoring market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 to 2025.
in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Global market, the following companies are covered:
Abbott
GE Healthcare
Hill-Rom
Medtronic
Philips Healthcare
Market Segment by Product Type
Electrocardiogram (ECG) Devices
Implantable Loop Recorder (ILRs)
Cardiac Event Monitors
Cardiac Output Monitoring (COM) Devices
Market Segment by Application
Home and Ambulatory
Hospital
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the companys product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Cardiac Monitoring market for the forecast period 2020 - 2025?
• What are the driving forces in the Cardiac Monitoring market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Cardiac Monitoring industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?